Lupin launches plaque psoriasis treatment spray in US market

Quoting IQVIA MAT May 2018 data, Lupin said Desoximetasone Topical Spray, 0.25 per cent, had annual sales of approximately USD 18.7 million in the US.

from Healthcare/Biotech-Industry-The Economic Times https://ift.tt/2On0YVE
via IFTTT